With a revenue increase of 11.05% in the third quarter 2026, year on year to cumulative value of $250,735 million, Cardinal Health Inc 's revenue per employee grew on a trailing twelve months basis to $ 3,923,865. The productivity of Cardinal Health Inc 's employees was 0.0%, above the company average. Within the Retail sector Cardinal Health Inc achieved the highest revenue per employee. While Cardinal Health Inc 's total ranking has deteriorated compared to the previous quarter from 25 to 45. Cardinal Health Inc has 63,900 employees.
Cardinal Health s New Role as Distributor for Telix Pharmaceuticals Sparks Mixed Sentiments Amid Stock Struggles In a strategic move poised to bolster its market position, Telix Pharmaceuticals Limited recently announced Cardinal Health, Inc. as the U.S. commercial distributor for its innovative radiopharmaceutical product, Zircaix (TLX250-CDx), intended for the imaging of kidney cancer. This partnership, however, arrives at a turbulent moment for Cardinal Health, which is grappling with stock performance challenges and investor skepticism. Zircaix, a PET agent, represents a pivotal advancement in the fight against kidney cancer, promising accuracy in diagnostic imaging. Pending regulatory approval, Cardinal Health is set to play a critical role in the logistics surrounding the distribution of this technology across the U.S. healthcare landscape. However, beneath the surface of this announcement lies a troubling narrative concerning Cardinal Health s recent performance metrics and market position.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
